- Home
- AXGN vs HTD Comparison
AXGN vs HTD Comparison
Compare AXGN & HTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- HTD
- Stock Information
- Founded
- AXGN N/A
- HTD 2004
- Country
- AXGN United States
- HTD United States
- Employees
- AXGN N/A
- HTD N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- HTD Finance Companies
- Sector
- AXGN Health Care
- HTD Finance
- Exchange
- AXGN Nasdaq
- HTD Nasdaq
- Market Cap
- AXGN 887.3M
- HTD 818.5M
- IPO Year
- AXGN N/A
- HTD N/A
- Fundamental
- Price
- AXGN $17.16
- HTD $22.83
- Analyst Decision
- AXGN Strong Buy
- HTD
- Analyst Count
- AXGN 5
- HTD 0
- Target Price
- AXGN $23.00
- HTD N/A
- AVG Volume (30 Days)
- AXGN 611.3K
- HTD 92.3K
- Earning Date
- AXGN 05-01-2025
- HTD 01-01-0001
- Dividend Yield
- AXGN N/A
- HTD 8.59%
- EPS Growth
- AXGN N/A
- HTD N/A
- EPS
- AXGN N/A
- HTD N/A
- Revenue
- AXGN $187,338,000.00
- HTD N/A
- Revenue This Year
- AXGN $18.20
- HTD N/A
- Revenue Next Year
- AXGN $16.48
- HTD N/A
- P/E Ratio
- AXGN N/A
- HTD N/A
- Revenue Growth
- AXGN 17.81
- HTD N/A
- 52 Week Low
- AXGN $5.55
- HTD $16.17
- 52 Week High
- AXGN $21.00
- HTD $22.13
- Technical
- Relative Strength Index (RSI)
- AXGN 41.40
- HTD 43.43
- Support Level
- AXGN $16.79
- HTD $22.65
- Resistance Level
- AXGN $20.39
- HTD $23.46
- Average True Range (ATR)
- AXGN 1.31
- HTD 0.35
- MACD
- AXGN -0.25
- HTD -0.08
- Stochastic Oscillator
- AXGN 19.67
- HTD 15.65
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About HTD John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest
John Hancock Tax-advantaged Div Inc Fd is a closed-end, diversified management investment company. Its investment objective is to provide a high after-tax total return from dividend income and capital appreciation. The fund's portfolio composition consists of common stocks, preferred securities, corporate bonds, convertible bonds, and short-term investments. Its sector composition comprises utilities, financials, energy, telecommunication services, industrials, healthcare, real estate, consumer discretionary and short-term investments.